BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 5086245)

  • 1. Neurochemical properties of adrenergic nerves regenerated after 6-hydroxydopamine.
    Jonsson G; Sachs C
    J Neurochem; 1972 Nov; 19(11):2577-85. PubMed ID: 5086245
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative microfluorimetric and neurochemical studies on degenerating adrenergic nerves.
    Sachs C; Jonsson G
    J Histochem Cytochem; 1973 Oct; 21(10):902-11. PubMed ID: 4753440
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of drugs on the 6-hydroxydopamine induced degeneration of adrenergic nerves.
    Jonsson G; Malmfors T; Sachs C
    Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):543-56. PubMed ID: 5034513
    [No Abstract]   [Full Text] [Related]  

  • 4. Degeneration and regrowth of adrenergic nerve fibers in the rat peripheral tissues after 6-hydroxydopamine.
    de Champlain J
    Can J Physiol Pharmacol; 1971 Apr; 49(4):345-55. PubMed ID: 5124933
    [No Abstract]   [Full Text] [Related]  

  • 5. Degeneration and regeneration of adrenergic nerves in mesenteric blood vessels, iris and atrium of the rat after 6-hydroxydopamine injection.
    Lorez HP; Kuhn H; Bartholini G
    J Neurocytol; 1975 Apr; 4(2):157-76. PubMed ID: 1123654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degenerative and nondegenerative effects of 6-hydroxydopamine on adrenergic nerves.
    Jonsson G; Sachs C
    J Pharmacol Exp Ther; 1972 Mar; 180(3):625-35. PubMed ID: 4335111
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of 6-hydroxydopamine and guanethidine on peripheral adrenergic nerves in the guinea pig.
    O'Donnell SR; Saar N
    Eur J Pharmacol; 1974 Oct; 28(2):251-6. PubMed ID: 4607945
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of 6-hydroxydopamine on the uptake and storage of noradrenaline in sympathetic adrenergic neurons.
    Jonsson G; Sachs C
    Eur J Pharmacol; 1970 Feb; 9(2):141-55. PubMed ID: 5437149
    [No Abstract]   [Full Text] [Related]  

  • 9. 6-hydroxydopamine, 6-hydroxydopa and degeneration of adrenergic nerves.
    de Champlain J; Nadeau R
    Fed Proc; 1971; 30(3):877-85. PubMed ID: 4324975
    [No Abstract]   [Full Text] [Related]  

  • 10. Correlation of norepinephrine content with observations of adrenergic nerves after a single dose of 6-hydroxydopamine in the rat.
    Goldman H; Jacobowitz D
    J Pharmacol Exp Ther; 1971 Jan; 176(1):119-33. PubMed ID: 5569629
    [No Abstract]   [Full Text] [Related]  

  • 11. A stimulatory effect by nerve growth factor on the regrowth of adrenergic nerve fibres in the mouse peripheral tissues after chemical sympathectomy with 6-hydroxydopamine.
    Bjerre B; Björklund A; Mobley W
    Z Zellforsch Mikrosk Anat; 1973 Dec; 146(1):15-43. PubMed ID: 4777497
    [No Abstract]   [Full Text] [Related]  

  • 12. Degeneration of adrenergic nerves produced by 6-hydroxydopamine.
    Malmfors T; Sachs C
    Eur J Pharmacol; 1968 Apr; 3(1):89-92. PubMed ID: 5654676
    [No Abstract]   [Full Text] [Related]  

  • 13. Ontogenesis of sympathetic fibers after neonatal 6-hydroxydopamine treatment in the rat.
    Singh B; De Champlain J
    Can J Physiol Pharmacol; 1974 Apr; 52(2):304-18. PubMed ID: 4134541
    [No Abstract]   [Full Text] [Related]  

  • 14. Degeneration of central noradrenaline neurons after 6-hydroxydopamine in newborn animals.
    Sachs C; Jonsson G
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):203-20. PubMed ID: 4671892
    [No Abstract]   [Full Text] [Related]  

  • 15. Uptake and accumulation of 3 H-6-hydroxydopamine in adrenergic nerves.
    Jonsson G; Sachs C
    Eur J Pharmacol; 1971 Sep; 16(1):55-62. PubMed ID: 5157530
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of 6-hydroxydopamine neurotoxicity.
    Cohen G; Allis B; Winston B; Mytilineou C; Heikkila R
    Eur J Pharmacol; 1975 Aug; 33(1):217-21. PubMed ID: 1175689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for degeneration of sympathetic nerve terminals caused by the ortho- and para-quinones of 6-hydroxydopamine.
    Heikkila RE; Mytilineou C; Côté L; Cohen G
    J Neurochem; 1973 May; 20(5):1345-50. PubMed ID: 4716829
    [No Abstract]   [Full Text] [Related]  

  • 18. Noradrenaline nerve terminals in the cerebral cortex: effects on noradrenaline uptake and storage following axonal lesion with 6-hydroxydopamine.
    Lidbrink P; Jonsson G
    J Neurochem; 1974 May; 22(5):617-26. PubMed ID: 4152079
    [No Abstract]   [Full Text] [Related]  

  • 19. Microfluorimetric studies on the formaldehyde-induced fluorescence of noradrenaline in adrenergic nerves of rat iris.
    Jonsson G
    J Histochem Cytochem; 1969 Nov; 17(11):714-23. PubMed ID: 5386300
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis of noradrenaline from 3,4-dihydroxyphenylalanine (DOPA) and dopamine in adrenergic nerves of mouse atrium--effect of reserpine, monoamine oxidase and tyrosine hydroxylase inhibition.
    Jonsson G; Sachs C
    Acta Physiol Scand; 1970 Nov; 80(3):307-22. PubMed ID: 5486459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.